Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 24, 2017 EUO, JO, CRVP, PCRX, FRP, MYY Are Seasonally Ripe To Go Down In the Next Five Weeks
March 24, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of ProShares UltraShort Euro (NYSE:EUO), iPath Dow Jones-AIG Coffee Total Return Sub-IndexSM ETN (NYSE:JO), Crystal Rock Holdings Inc (NYSE:CRVP), Pacira Pharmaceuticals Inc. (NASDAQ:PCRX), FairPoint Communications Inc (NASDAQ:FRP), ProShares Short MidCap400 (NYSE:MYY) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date EUO ProShares UltraShort Euro -1.69% 87.50% (7 of 8) Thursday, March 30th 2017 JO iPath Dow Jones-AIG Coffee Total Return Sub-IndexSM ETN -1.75% 87.50% (7 of 8) Wednesday, March 29th 2017 CRVP Crystal Rock Holdings Inc -8.14% 82.61% (19 of 23) Wednesday, April 19th 2017 PCRX Pacira Pharmaceuticals Inc. -1.86% 100.00% (6 of 6) Monday, March 27th 2017 FRP FairPoint Communications Inc -1.31% 66.67% (4 of 6) Monday, March 27th 2017 MYY ProShares Short MidCap400 -2.58% 90.00% (9 of 10) Friday, March 31st 2017ProShares UltraShort Euro (NYSE:EUO) - Proshares Ultrashort Euro.
iPath Dow Jones-AIG Coffee Total Return Sub-IndexSM ETN (NYSE:JO) - ipath Dow JonesUbs Coffee Subindex Total Return Etn due June 24 2038.
Crystal Rock Holdings Inc (NYSE:CRVP) - Crystal Rock Holdings, Inc. produces, markets, and distributes bottled water to homes and offices in New England, New York, and New Jersey. The company also distributes various coffee, tea, and other hot beverage products and related supplies; consumable products used in the office; other refreshment products, including soft drinks and snacks; and office products, as well as provides vending services. In addition, it rents and sells water coolers in various consumer preferences such as cold, or hot and cold dispensing units to customers to dispense bottled water; units to commercial accounts that filter water from the existing source on site; and coffee brewing equipment. The company markets and distributes its water products under the Crystal Rock Waters and Vermont Pure Natural Spring Water brand names; Crystal Rock Water under the Cool Beans, Baronet, and Keurig Green Mountain brands; and office products under the Crystal Rock Office brand name. It distributes its products directly, as well as through third party distributors; and Internet. Crystal Rock Holdings, Inc. was founded in 1914 and is headquartered in Watertown, Connecticut..
Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) - Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. The company develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. Its lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for infiltration into the surgical site to produce postsurgical analgesia. The company also markets DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a life-threatening complication of lymphoma, a cancer of the immune system. Its development pipeline comprises DepoTranexamic Acid, a long-acting local antifibrinolytic agent, which is in Phase II clinical development for the treatment or prevention of excessive blood loss during surgery by preventing the breakdown of a clot; and DepoMeloxicam, a long-acting non-steroidal anti-inflammatory drug, which is in preclinical development for the treatment of acute postsurgical pain. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey..
FairPoint Communications Inc (NASDAQ:FRP) - FairPoint Communications, Inc. provides communications services to business, wholesale, and residential customers in the United States. It provides high capacity data services, including optical, Ethernet, IP services, and Ethernet virtual circuit technology for cellular backhaul; and private line special access services, as well as hosted primary branch exchange services over its Ethernet network. The company also offers Internet services, including cable modem Internet service, and fiber to the home and wireless Internet access services; and data center colocation services. In addition, it provides local calling services, such as basic local lines and local private lines; long distance services; and 9-1-1 services. Further, the company offers network transport services, including special access services, such as DS-1 and DS-3 services; and high speed digital services comprising Ethernet-based services provisioned over fiber and copper facilities, as well as network switched, intrastate, and intrastate access services. Additionally, it publishes telephone directories; and provides video services, including cable and IP television video-over-digital subscriber line services. The company also provides project-based implementation support services. As of December 31, 2016, it operated approximately 306,600 broadband subscribers; 15,700 Ethernet circuits; and 366,100 residential voice lines in 17 states. The company was incorporated in 1991 and is headquartered in Charlotte, North Carolina..
ProShares Short MidCap400 (NYSE:MYY) - SHORT MIDCAP400.
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net
- WOPRAI
- support@woprai.com